A-MANSIA BIOTECH
A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering the intestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
A-MANSIA BIOTECH
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-01-01
Address:
Louvain-la-neuve, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.a-mansia.com
Total Employee:
1+
Status:
Active
Total Funding:
19.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving
Similar Organizations
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Industries
Innovation Industries investment in Seed Round - A-Mansia Biotech
Seventure Partners
Seventure Partners investment in Series A - A-Mansia Biotech
Pierre Drion
Pierre Drion investment in Series A - A-Mansia Biotech
Fonds Vives II (University of Louvain, UCL)
Fonds Vives II (University of Louvain, UCL) investment in Series A - A-Mansia Biotech
Nivelinvest
Nivelinvest investment in Series A - A-Mansia Biotech
the SRIW Life Sciences
the SRIW Life Sciences investment in Series A - A-Mansia Biotech
Wallonia Regional Government
Wallonia Regional Government investment in Grant - A-Mansia Biotech
Official Site Inspections
http://www.a-mansia.com Semrush global rank: 184.02 K Semrush visits lastest month: 430.29 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "A-Mansia Biotech"
A Mansia
Aug 9, 2024 This vital step aligns with their goal to make A-Mansia’s solutions available to those at risk of cardiovascular disease, obesity, and diabetes. The revolution has already begun. As new research findings unfold and more …See details»
A-Mansia Biotech - Crunchbase Company Profile & Funding
A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut …See details»
A-Mansia - VentureRadar
" A-Mansia is a Belgian microbiome spinoff company based on discoveries made by its founding scientists Prof. Willem M. de Vos (Wageningen University – The Netherlands) & Prof. Patrice …See details»
A-Mansia Company Profile - Office Locations, Competitors ... - Craft
A-Mansia is a microbiome company that specializes in the products based on the properties of Akkermansia muciniphila bacterium. It is engaged in the development of nutritional …See details»
THE AKKERMANSIA COMPANY – Wagralim
A-Mansia est une société belge de microbiome (spin-off) basée sur les découvertes du scientifique fondateur Prof. Willem de Vos (Université de Wageningen – Pays-Bas) et Prof Patrice Cani (UCLouvain – Belgique).See details»
The Akkermansia Company™ and Metagenics launch …
Jun 29, 2022 About The Akkermansia Company™ Founded in 2016, The Akkermansia Company™ (previously A-Mansia) is a spin-off company located in Belgium and specialized in the microbiome. It builds on the findings of its …See details»
A-Mansia Biotech - Funding, Financials, Valuation & Investors
A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. Search Crunchbase. ... How much funding has this …See details»
A-Mansia Biotech S.A. - life-sciences-europe.com
Jan 1, 2016 A-Mansia is developing health products based on the unique properties of the Akkermansia muciniphila bacteria. The Company has secured €13m in a series A financing …See details»
A-Mansia Biotech - Contacts, Employees, Board Members
Organization. A-Mansia Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... A-Mansia Biotech has 2 board …See details»
A-Mansia - Manufacturer Of Metabolic Health Products - Medical …
A-Mansia has secured through exclusive licenses and proprietary patents a key Intellectual Property (IP) portfolio surrounding Akkermansia muciniphila.The portfolio includes …See details»
The Akkermansia Company extends international reach …
Oct 13, 2022 Pasteurised Akkermansia muciniphila was developed The Akkermansia Company, then known as A-Mansia, a spin-off of the Universities of Wageningen (Netherlands) and UCLouvain (Belgium). The bacterium was …See details»
Innovative A-mansia biotech - The Akkermansia Company
Mar 10, 2023 A-Mansia Biotech Drives New Weight Management Product from The Akkermansia Company Many food supplements exist, but few can justify their claims. A …See details»
A-Mansia Biotech’s pasteurised Akkermansia muciniphila is the …
Sep 2, 2021 “Products based on Akkermansia muciniphila open the door to a new generation of nutritional supplements, rooted in a deep understanding of microbiome function. This EFSA …See details»
Series A Financing Pushes A-Mansia's Microbiome Technology …
Published on 27/04/2018. A-Mansia Biotech has raised €13M in Series A financing led by Seventure Partners. The funding will be used to develop products derived from one of the …See details»
University of Louvain and Wageningen University launch their new …
A-Mansia is the latest co-spin-off from the University of Louvain (UCL) and Wageningen University. It aims to develop Akkermansia-based products. Three years from now, a first …See details»
A-Mansia: la bactérie anti-obésité bientôt accessible
Et c’est désormais au cœur d’une nouvelle biotech belge, A-Mansia Biotech, que cette bactérie pourrait devenir à l’avenir une véritable innovation dans la prévention du surpoids et de …See details»
Belgian Microbiome Start-up A-Mansia Announces €13m First …
Apr 28, 2018 A-Mansia Biotech S.A. (A-Mansia), the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. …See details»
A-Mansia | VentureRadar
A-Mansia is a Belgian microbiome spinoff company based on discoveries made by its founding scientists Prof. Willem M. de Vos (Wageningen University – The Netherlands) & Prof. Patrice …See details»
From lab to market: A-Mansia secures funding for “unique” gut …
30 Apr 2018 --- Belgian microbiome company A-Mansia Biotech has raised €13 million in first close Series A financing, pushing forward development of one their unique discoveries – the …See details»
A Mansia
The World Health Organization (WHO) has called diabetes the “21 st century epidemic”. According to the 2019 figures published by the International Diabetes Federation, 463 million …See details»